3rd Quarter - Report

NOSSAMAN LLP for AMERISOURCEBERGEN CORPORATION (FORMERLY "AMERISOURCEBERGEN SPECIALTY GROUP")

Firm
Client
Income
$30,000
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Taxation/Internal Revenue Code TAX

Repeal of LIFO (Last in, First Out).

LobbyistCovered position, as disclosed
SHELBY LYNNE HAGENAUER —
BRENT HEBERLEE —
TIMOTHY W JENKINS —
SHERRY HARPER WIDICUS —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Pharmacy PHA

(H.R. 696/S. 506) Medicare Prompt Pay Discount Exclusion,legislation to ensure more appropriate general payment amount for drugs & biologicals under Part B of the Medicare Program by excluding customary prompt-pay discounts extended to wholesalers from the manufacturer's average sales price. Legislation to exclude cancer drugs from sequestration cuts. HR471/S483 Ensuring Patient Access and Effective Drug Enforcement Act of 2015.

LobbyistCovered position, as disclosed
SHELBY LYNNE HAGENAUER —
BRENT HEBERLEE —
TIMOTHY W JENKINS —
PAUL S QUINN —
SHERRY HARPER WIDICUS —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 506 (114th), H.R. 696 (114th), H.R. 471 (114th)

Medicare/Medicaid MMM

(H.R.696/S.506) legislation to ensure more appropriate general payment amount for drugs and biologicals under Part B of the Medicare Program by excluding customary prompt-pay discounts extended to wholesalers from the manufacturer's average sales price (ASP) generally (in the context of deficit reduction).

LobbyistCovered position, as disclosed
SHELBY LYNNE HAGENAUER —
BRENT HEBERLEE —
TIMOTHY W JENKINS —
SHERRY HARPER WIDICUS —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 696 (114th), S. 506 (114th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.